Sarepta Therapeutics
SRPT
SRPT
177 hedge funds and large institutions have $1.08B invested in Sarepta Therapeutics in 2016 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 50 closing their positions.
Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.43%
Holding in Top 10
4
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-63.64%
% of All Funds
0.1%
New
43
Increased
63
Reduced
54
Closed
50
Calls
$212M
Puts
$195M
Net Calls
+$17.1M
Net Calls Change
+$274M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
QI
226
QS Investors
New York
| – | – | -8 | Closed |
|
227
Marshall Wace
London,
United Kingdom
| – | – | – | – |
|
228
First Eagle Investment Management
New York
| – | – | – | – |
|
|
SCM
229
Sio Capital Management
New York
| – | – | – | – |
|
|
MIM
230
Monashee Investment Management
Boston,
Massachusetts
| – | – | – | – |
|
|
PG
231
PEAK6 Group
Chicago,
Illinois
| – | – | – | – |
|
|
FANJ
232
Financial Architects (New Jersey)
Marlton,
New Jersey
| $0 | 5 | – | – |
|
233
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
ID
234
Integral Derivatives
New York
| – | – | – | – |
|
235
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
236
Walleye Trading
New York
| – | – | – | – |
|
|
KCM
237
Kingdon Capital Management
New York
| – | – | – | – |
|
|
NCM
238
Nantahala Capital Management
New Canaan,
Connecticut
| – | – | – | – |
|